Induction of interstrand crosslinks (ICLs) in chromosomal DNA is considered a major reason for the antiproliferative effect of psoralen plus ultraviolet A (PUVA). It is unclear as to whether PUVA-induced cell cycle arrest is caused by ICLs mechanically stalling replication forks or by triggering cell cycle checkpoints. Cell cycle checkpoints serve to maintain genomic stability by halting cell cycle progression to prevent replication of damaged DNA templates or segregation of broken chromosomes. Here, we show that HaCaT keratinocytes treated with PUVA arrest with S-phase DNA content. Cells that had completed DNA replication were not perturbed by PUVA and passed through mitosis. Cells treated with PUVA during G1-phase continued traversing G1 until arresting in early S-phase. PUVA induced rapid phosphorylation of the Chk1 checkpoint kinase at Ser345 and a concomitant decrease in Cdc25A levels. Chk1 phosphorylation, decrease of Cdc25 A levels and S-phase arrest were abolished by caffeine, demonstrating that active checkpoint signaling rather than passive mechanical blockage by ICLs causes the PUVA-induced replication arrest. Overexpression of Cdc25A only partially overrode the S-phase arrest, suggesting that additional signaling events implement PUVA-induced S-phase arrest.
Introduction
Upon activation by ultraviolet A light (UVA), psoralens form mono-or bifunctional adducts with pyrimidine bases. Bifunctional adducts result in covalent crosslinking of opposite strands of DNA (interstrand crosslinks ¼ ICLs) (Gasparro, 1988) . In medicine, the combination of psoralens and ultraviolet A irradiation (PUVA) is used for the treatment of several hyperproliferative skin diseases, most notably psoriasis. PUVA inhibits the proliferation of various cell types both in vitro and in vivo (reviewed in Luftl et al., 1998) . ICLs are considered to be the main reason for the antiproliferative effects of PUVA. However, the exact molecular mechanism by which ICLs inhibit cell growth is not known.
Cell cycle checkpoints serve to maintain genomic stability by halting cell cycle progression in response to incomplete replication, incorrect chromosome segregation or chromosomal damage (Nurse, 1997; Weinert, 1998) . In mammalian cells, upstream signaling elements in these responses are the phosphatidylinositol 3-kinase family members ataxia telangiectasia mutated (ATM) and ATM-and Rad3-related protein (ATR) (Bentley et al., 1996; Cimprich et al., 1996) . ATM and ATR phosphorylate and thereby activate the Chk1 and Chk2/ Cds1 checkpoint kinases (Matsuoka et al., 1998; Liu et al., 2000) , which in turn phosphorylate key promoters of the core cell cycle machinery, the Cdc25 dualspecificity phosphatases. There are three Cdc25 proteins in mammalian cells. While Cdc25C and Cdc25B promote progression from G2-phase into mitosis (Sadhu et al., 1990; Galaktionov and Beach, 1991; Sebastian et al., 1993) , Cdc25A regulates entry into S-phase (Hoffmann et al., 1994; Jinno et al., 1994) . Phosphorylation by Chk1 or Chk2/Cds1 renders Cdc25 phosphatases inactive by inhibiting their phosphatase activity (Blasina et al., 1999a; Furnari et al., 1999) , sequestration in the cytoplasm (Peng et al., 1997; Sanchez et al., 1997) or targeted degradation via the proteasome (Mailand et al., 2000; Zhao et al., 2000) . Here, we have investigated the effect of PUVA on cell cycle progression in HaCaT keratinocytes. We present data to suggest that PUVA arrests HaCaT cells exclusively during DNA replication, and that this arrest is not caused by passive stalling of replication forks by ICLs but rather by active checkpoint signaling involving Chk1 and Cdc25A.
Results

PUVA arrests cells at various stages of S-phase
To test for the effect of PUVA on the cell cycle, HaCaT keratinocytes were pulse labeled with bromo-deoxyuridine (BrdU) prior to PUVA treatment. Doses were chosen in a range equaling that used in vivo during PUVA therapy. If not indicated otherwise, the concen-tration of 8-methoxy-psoralen (MOP) was constant in all experiments (0.1 mg/ml) and corresponded to the MOP serum level found in patients after ingestion of MOP (Ljunggren et al., 1980) . The dose of UVA was increased from 0.05 to 1.0 J/cm 2 , the latter representing a dose applied early in the course of PUVA therapy. At 12 h following treatment with a low dose (0.05 J/cm 2 ), cells seemed to accumulate in the G2/M peak of the PI histogram (Figure 1b) . However, mathematical modeling using ModFit cell cycle analysis software revealed that most cells in that peak had a DNA content slightly less than twofold of that of G1 cells. Most of these near4n cells were BrdU positive while the fraction of BrdU negative cells was significantly lower than in untreated cells. In response to increasing doses of PUVA, cells arrested at successively earlier stages of S-phase ( Figure  1c-f) . After 1.0 J/cm 2 (Figure 1e ), the cell cycle profile was reminiscent of that of asynchronous cells harvested immediately after a BrdU pulse (Figure 1(g) , except that G2 cells were absent after PUVA. This indicated that most of the cells had not progressed in the cell cycle during the 12 h following PUVA treatment (Figure 1e ). To further increase the PUVA dose, the concentration of MOP was increased rather than the UVA dose, since UVA doses higher than 1.0 J/cm 2 caused cell cycle effects by themselves (not shown) (Figure 1f ). Still. G2/M cells were absent after PUVA. Cell cycle effects of PUVA were identical irrespective of whether cells were pulsed with BrdU or not (data not shown). The response to PUVA clearly differed from the one observed after other DNA damaging agents such as ultraviolet or ionizing radiation (Orren et al., 1995; Herzinger et al., 1995; Tobey, 1975) . There were two possible explanations for this observation: PUVA-induced damage could be detrimental to cells in G2-phase, thus eliminating these cells from our analysis. Alternatively, G2 cells might not be disturbed by PUVA-induced damage, and can pass freely into the subsequent G1-phase.
Cells are not arrested in G2 by PUVA
To determine whether cells that are in G2 by the time of PUVA treatment can enter mitosis, cells were blocked in metaphase with nocodazole and the number of mitotic cells was counted at various time points after PUVA. During the first 4 h following PUVA, cells were entering mitosis at the same rate as mock-treated controls, indicating that G2 cells are not arrested at the G2/M border by PUVA (Figure 2A) . After 6 and 8 h, no more cells entered mitosis, suggesting that all cells had left G2 by that time. To specifically trace cells that were in G2 during PUVA treatment, cells were pulsed with BrdU and PUVA-treated after a pause of 1 or 2 h. With increasing the interval between the BrdU pulse and PUVA treatment, an ever larger part of BrdU-positive cells can be expected to represent cells that had completed DNA replication and were already in G2 by the time of PUVA treatment ( Figure 2B ). Cells were harvested and processed for FACS analysis 12 h after PUVA or mock treatment. By that time, most of the mock-treated BrdU-labeled cells had entered the subsequent G1, and some were already beginning to enter S-phase again ( Figure 
Cells are not arrested in G1 by PUVA
To determine whether PUVA treatment during G1-phase can prevent cells from entering S-phase, cells were synchronized in G0 by serum depletion for 48 h. followed by restimulation with 10% FCS. In the absence of PUVA. cells commenced DNA synthesis approximately 16 h following readdition of serum, and had traversed about 2/3 of S-phase by 24 h (Figure 3a , panels 1-5). When treated with PUVA 8 h after readdition of serum, cells still initiated replication at 16 h ( Figure 3a , panel 8, arrow) suggesting that passage through G1 was unperturbed by PUVA. However, once having entered S-phase cells were arrested and did not continue DNA replication (Figure 3a, panel 9 ). Since traversion through G1-phase cannot be monitored by changes in DNA content, we used phosphorylation of the retinoblastoma protein pRb as a biochemical marker for G1 progression. Being hypophosphorylated in quiescent cells. pRb is increasingly phosphorylated as cells approach S-phase (Figure 3b ). Cells treated with PUVA at 8 h continued to phosphorylate pRb like untreated controls (Figure 3b) , showing that PUVA does not arrest cells in G1. To exclude the possibility that BrdU incorporation after PUVA might reflect DNA repair rather than replication, cells were arrested in G1 with the Cdk-inhibitor roscovitine after PUVA. In the absence of roscovitine, cells incorporated BrdU during the 16 h following PUVA but did not show any increase in DNA content (from hours 8 to 24, Figure 3c , panel 3). When treated with roscovitine after PUVA, cells did not incorporate BrdU (Figure 3c , panel 5), demonstrating that BrdU incorporation does not reflect repair DNA synthesis.
PUVA-induced replication block is mediated by a caffeine-sensitive checkpoint signal
The S-phase arrest induced by PUVA might be caused by a checkpoint signal sensing DNA damage or incomplete replication. Alternatively, it can be explained as consequence of a passive mechanical block of replication forks by ICLs. In the latter case, agents interfering with checkpoint signaling should not have an effect on the S-phase arrest. Caffeine is known to override replication or DNA damage checkpoints, likely by inhibiting the ATM and/or ATR checkpoint kinases (Blasina et al., 1999b; Esashi and Yanagida, 1999; Sarkaria et al., 1999; Tominaga et al., 1999; Zhou et al., 2000) . To test whether active checkpoint signaling is involved in the PUVA-induced cell cycle arrest, we incubated cells with caffeine prior to PUVA treatment and for the subsequent 12 h. Most cells were arrested in S-phase by PUVA in the absence of caffeine (Figure 4a ). In contrast, upon addition of caffeine, cells passed through S-phase and mitosis, and entered the subsequent G1-phase (Figure 4b , BrdU-positive cells, upper left), similar to mock-treated controls (Figure 4d ). For unknown reasons, addition of caffeine caused a slight slowdown of cell cycle progression in mock-treated controls (compare panels c and d).
PUVA-induced replication block involves Chk1 and Cdc25A
These findings suggested that PUVA induced a checkpoint signal in HaCaT cells. Chk1 is one of the checkpoint kinases acting directly downstream of ATM/ATR. In response to DNA damage or incomplete replication, Chk1 is activated by phosphorylation at Ser345 (Liu et al., 2000; Zhao and Piwnica-Worms, 2001 ). Using an antibody specific for the Ser345-phosphorylated form of Chk1, we found that PUVA phosphorylates Chk1 ( Figure 5, lanes 2 and 7) . The overall level of Chk1 remained unaltered. Increase of Chk1 phosphorylation occurred within 1 h following PUVA and was therefore unlikely to be caused by a positional effect due to synchronization of cells. Phosphorylation of Chk1 was mirrored by a decrease in the level of Cdc25A, a dual-specificity phosphatase known to promote S-phase entry and progression ( Figure 5, lanes 2 and 7) . Addition of caffeine prevented the PUVA-induced phosphorylation of Chk1 and the decrease in Cdc25A level ( Figure 5, lanes 3 and 8) , suggesting that caffeine allowed cells to by-pass the S- 
Overexpression of Cdc25A partially overrides PUVA-induced replication arrest
If decrease in Cdc25A levels was essential for the PUVA-induced S-phase arrest, overexpression of exogenous Cdc25A should interfere with such an arrest. To test this, we employed a rat fibroblast cell line that stably expresses a Flag-tagged human Cdc25A under the control of a tetracycline repressible promoter (Blomberg and Hoffmann. 1999) . Withdrawal of tetracycline for 24 h caused a strong induction of Cdc25A (Figure 6a , lane 3) Like endogenous Cdc25A, exogenous Cdc25A was reduced in response to PUVA, but still expressed at much higher than endogenous levels (Figure 6a, lane 4) . Cells overexpressing Cdc25A were no longer arrested at the beginning of S-phase by PUVA but rather progressed to about mid-S-phase (Figure 6b, panel 4) . However, unlike with caffeine (compare Figure 4) , abrogation of the arrest was incomplete since cells failed to enter the subsequent G1-phase. This suggests that downregulation of Cdc25A is a necessary, yet not sufficient event in the induction or maintenance of PUVA-induced S-phase arrest, implicating other caffeine-sensitive signaling events acting in parallel to Cdc25A. 
Discussion
Our findings provide evidence that PUVA induces a checkpoint signal resulting in S-phase arrest and a decrease of Cdc25A levels. Mechanical blockage of replication forks by ICLs is not sufficient to prevent continuation of DNA replication since the replication arrest can be overridden by caffeine. The fact that PUVA-induced cell cycle arrest is restricted to S-phase suggests further that ICLs do not trigger a DNA damage checkpoint signal per se but rather require the context of ongoing replication to do so. The lack of a G2/M-arrest following PUVA was unexpected since many other DNA damaging agents such as UV or ionizing radiation have been shown to cause a G2/M arrest (Tobey, 1975; Herzinger et al., 1995; Orren et al., 1995) . Induction of a 4n-DNA peak by low doses of PUVA has also been interpreted to represent a G2-arrest, but this was not distinguished from a late S-phase arrest (Cohen et al., 1981; Varga et al., 1982) . Using presynchronized cells, Akkari et al. (2000) recently showed that PUVA-induced ICLs cause cell cycle arrest in S-phase, but not in G2-phase. DNA double-strand breaks represent the most relevant lesion for the G2/M checkpoint since they may lead to inaccurate chromosome segregation during mitosis. Other than ionizing radiation, PUVA does not directly induce DNA double-strand breaks. However, DNA double-strand breaks may result from repair of ICLs. In yeast, ICLs have been shown to be repaired by homologous recombination repair, thus transiently giving rise to double-strand breaks (Jachymczyk et al., 1981; Magana-Schwencke et al., 1982; de Andrade et al., 1989) . Increased rates of homologous recombination have also been found after ICL inducing agents in mammalian cells (Wang et al., 1988) . However, no signs of chromosomal breakage could be found during mitosis in cells that had been PUVA treated during G2, leading to the suggestion that homologous recombination repair might be restricted to cell cycle phases other than G2 (Akkari et al., 2000) . Repair of ICLs has been estimated to occur at a rate of 11 ICLs per genome (Meniel et al., 1995) per hour, which is rather slow when compared to the approximately 96 000 ICLs induced per genome by 1 J/cm 2 UVA/0.1 mg/ml MOP (Gunther et al., 1995) . The presumable lack of a relevant amount of strand breaks in G2 cells after PUVA could be explained either by the slow rate or the complete lack of recombination repair during G2-phase. Another reason for the lack of a checkpoint response outside S-phase might be that, as opposed to other ICL inducing agents such as platinum compounds or nitrogen mustard. PUVA-induced ICLs cause only minor distortion to the DNA double helix (Dronkert and Kanaar, 2001) .
Eucaryotic DNA replication is initiated in a precise temporal order from many origins (Diffley, 1998) . Stalling of replication forks by ICLs interrupts DNA synthesis from the corresponding origin. At a constant concentration of MOP, the number of ICLs increases almost linearly with the UVA dose applied (Gasparro, 1988) . With increasing the number of ICLs, DNA synthesis should become less and less complete. Total block of replication can be expected if the number of ICLs exceeds that of origins of replication. However, an estimate of the ICLs induced in our experiments makes this unlikely to be the case here: 1 J/cm 2 UVA/ 0.1 mg/ml MOP induces approximately 1.6 ICLs per mbp while there are an estimated five origins per mbp in the human genome (Hamlin, 1992) . The number of relevant ICLs per origin might still be lower since part of the ICLs will be located in DNA that has already been replicated.
Direct evidence against a pure mechanical block is provided by the finding that caffeine can override the PUVA-induced replication arrest. Many replicationand DNA-damage checkpoints are sensitive to caffeine, resulting in inappropriate cell cycle progression (Busse et al., 1977; Busse et al., 1978; Schlegel and Pardee, 1986) . ATM and ATR have been identified as in vivo targets of caffeine (Blasina et al., 1999b; Hall-Jackson et al., 1999) . ATM and ATR are upstream regulators of the Chk1 and Chk2/Cds1 checkpoint kinases. Overexpression of a dominant-negative ATR protein in human cells has been shown to abrogate phosphorylation of Chk1 (Liu et al., 2000) . In Xenopus extracts, depletion of ATR prevented both phosphorylation of Chk1 and cell cycle arrest in response to HU or UVC (Guo et al., 2000; Hekmat-Nejad et al., 2000) . Similar to our observations with PUVA, caffeine has been reported Figure 5 PUVA-induced replication block involves Chk1 and Cdc25A. HaCaT cells were treated with PUVA (0.1 mg /ml MOP, 1.0 J/cm 2 UVA) or mock in the presence or absence of 2 mm caffeine and harvested 1 or 12 h later. Cell lysates were analysed by immunoblotting using antibodies to Cdc25A, phosphorylated Chk1 (Ser345) and total Chk1. Blotting with a-tubulin served as a control for equal loading PUVA-induced S-phase checkpoint C Joerges et al to abrogate Chk1 phosphorylation in response to UV C radiation or the replication inhibitor hydroxyurea (Mailand et al., 2000; Molinari et al., 2000; Feijoo et al., 2001) . Like PUVA, UVC and HU also result in a rapid decrease of Cdc25A abundance (Mailand et al., 2000; Molinari et al., 2000) . Conversely, overexpression of Cdc25A accelerates S-phase entry (Blomberg and Hoffmann, 1999; Sexl et al., 1999) and interferes with the replication checkpoint in response to hydroxyurea (HU) by inducing premature chromosome condensation (Molinari et al., 2000) . In our experiments, the PUVAinduced S-phase arrest was partially abrogated by overexpression of Cdc25A. However abrogation by Cdc25A was less complete than with caffeine, allowing cells only to precede to about mid-S-phase and not further. This finding suggests that Cdc25A downregulation is necessary, yet not sufficient, for the PUVAinduced S-phase arrest. Other caffeine-sensitive signaling pathways seem to operate in parallel. Evidence for such a parallel, yet ATM-dependent, pathway involving the Nbs1/Mre11/Rad50 complex has been provided recently (Falck et al., 2002) .
The existence of a DNA replication checkpoint in mammalian cells has first been demonstrated by cell Figure 6 Overexpression of Cdc25A partially overrides PUVA-induced replication arrest. (a) Rat fibroblasts expressing Flag-tagged human Cdc25A under the control of a tetracyline-regulated promoter were PUVA (lanes 2 and 4) or mock (lanes 1 and 3) treated 24 h after growing in the presence (promoter suppression) or absence (promoter induction) of 10 mg/ml tetracycline. Cell lysates were harvested 12 h later, and expression levels of Cdc25A were analysed by immunoblot using antibodies to Cdc25A or the Flag-tag, respectively. Blotting with a-tubulin served as a control for equal loading. (b) Cells were treated as in (a), pulsed with BrdU prior to PUVA or mock treatment, and analysed by FACS 12 h later PUVA-induced S-phase checkpoint C Joerges et al fusion experiments. Fusion of S-phase cells with G2 cells delays entry into mitosis, suggesting that the ongoing DNA synthesis generates a checkpoint signal (Rao and Johnson, 1970) . Damage to DNA by ionizing radiation during S-phase results both in a block of replication initiation and chain elongation. Cells lacking functional ATM are defective in this checkpoint and continue DNA synthesis in the presence of damage (radioresistant DNA synthesis ¼ RDS) (Painter and Young, 1980) . Prevention of RDS is controlled by the ATMChk2/Cds1-Cdc25A pathway and does not involve Chk1 (Falck et al., 2001) . In contrast, arrest in response to replication blocking agents such as HU has been shown to be caffeine sensitive yet independent of ATM. In addition, resumption of bulk DNA synthesis after release from replication block correlates with inactivation of Chk1 but not Chk2 (Chaturvedi et al., 1999; Feijoo et al., 2001) . Therefore, DNA damage and stalled replicons seem to generate distinct checkpoint signals during S-phase. The cell cycle arrest induced by PUVA shares the distinct features of a replication checkpoint: it is restricted to S-phase, it is sensitive to caffeine, and it involves phosphorylation of Chk1. We therefore speculate that a few stalled replication forks generate a checkpoint signal resulting in the halt of bulk replication.
Materials and methods
Reagents, cell lines
HaCaT cells were a kind gift of N Fusenig (Boukamp et al., 1988) and grown as described previously (Herzinger et al., 1995) . Rat fibroblasts overexpressing Cdc25A under the control of tetracycline were kindly provided by I Hoffmann (Blomberg and Hoffmann, 1999) . Antibodies were from Cell Signaling Technology (a-phospho-Chk1 (Ser345), a-phosphopRb (Ser807/811)). Santa Cruz (a-Cdc25A, a-Chk1), Sigma (anti-a-tubulin, anti-Flag M5), Promega (horseradish peroxidase (HRP)-conjugated secondary antibodies) or Becton Dickinson (a-BrdU-FITC). Roscovitine was from Calbiochem.
Cell irradiation
A total of 100 000 cells were seeded per 6 cm well. After 24 h, cells were incubated with MOP (0.1 mg/ml) in PBS for 20 min prior to irradiation with UVA (PUVA 200, Waldmann, Germany, equipped with 14 SYLVANIA F8T5 fluorescent tubes). For labeling of S-phase cells, BrdU (10 mm) was added during the preincubation period in some experiments. After irradiation, cells were washed twice with warm phosphatebuffered saline (PBS) and fed with complete medium (DMEM with 10% FCS). When indicated, caffeine (2 mm) was added 20 min prior to irradiation until harvest for FACS or immunoblotting, respectively. UVB irradiation was carried out in a parallel bank of three Philips TL20/12 fluorescent tubes.
Cell cycle analysis
After disaggregation with trypsin/EDTA solution cells were fixed in ice-cold 70% ethanol. Fixed cells were stained with a fluorescein isothiocyanate-conjugated a-BrdU antibody and propidium iodide (PI) (Sigma) as described (Herzinger and Reed, 1998) , and cell cycle phase distribution was analysed using a Becton Dickinson FACScan flow cytometer. For determination of the mitotic index, cells were seeded on glass coverslips 24 h prior to PUVA or mock treatment. Nocodazole (0.1 mg/ml) was added after treatment. After 1-8 h cells were fixed in 70% ethanol and nuclei were stained with DAPI.
Cell extracts and immunoblotting
Cells were lysed in ice-cold RIPA buffer (1% deoxycholate, 1% Triton X-400, 50 mm Tris-HCl pH 7.5,. 150 mm NaCl, 0.1% SDS) containing 0.1 mm sodium orthovanadate, 1.0 mm sodium fluoride and Completet proteinase inhibitor cocktail (Roche). Total cellular protein (10 mg) was boiled in 2 Â sample buffer (100 mm Tris-HCl pH 6.8, 200 mm dithiothreitol, 4% SDS, 20% glycerol, 0.001% bromphenol blue) and resolved on a 8% SDS/polyacrylamide gel. Proteins were transferred to polyvinylidene difluoride membranes (Immobilon, Millipore) by semidry electroblotting for 30 min at 15 V constant voltage. After transfer, membranes were stained with amido black (0.1% in 45% methanol/10% acetic acid) to control for equal loading. Membranes were then blocked in Milk Diluent (Kirkegaard & Perry Laboratories) overnight at 41C. Antibody incubations were carried out at room temperature. Dilutions were as follows: a-phospho-Chk1 (Ser345) 1 : 1000; a-Cdc25A 1 : 100; a-Chk1 1 : 200; a-tubulin 1 : 10 000; antiFlag 1:330; HRP-conjugated secondary antibodies 1 : 10 000). Antigen/antibody complexes were visualized using ECL Western blotting detection reagents (Amersham Biosciences).
Abbreviations UVA, ultraviolet A; ICLs, interstrand crosslinks; PUVA, psoralen plus ultraviolet A; MOP, 8-methoxy-psoralen; PBS, phosphate-buffered saline; BrdU, bromo-deoxy-uridine; PI, propidium iodide; HU, hydroxyurea; RDS, radio-resistant DNA synthesis..
